Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rinaldo

Showing results (291-300 of 324) with videos related to

Pageof 33
Sort By:
Journal of Virology|July 17, 2015
Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal TissuesTianyu He, Egidio Brocca-Cofano, Delbert G Gillespie, et al.
Advances in Virology|January 28, 2012
Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 InfectionJ Spindler, J Hackett, X Qiu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2008
Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopesCurtis P McMurtrey, Alina Lelic, Paolo Piazza, et al.
Influenza and Other Respiratory Viruses|April 17, 2020
Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016Goundappa K Balasubramani, Mary Patricia Nowalk, Theresa M Sax, et al.
Journal of Virology|July 20, 2012
Early HLA-B*57-restricted CD8+ T lymphocyte responses predict HIV-1 disease progressionCatherine A Brennan, F Javier Ibarrondo, Catherine A Sugar, et al.
Plos Pathogens|April 21, 2017
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activationRajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, et al.
Plos One|February 8, 2011
The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairmentTammy M Rickabaugh, Ryan D Kilpatrick, Lance E Hultin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 31, 2013
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trialBenigno Rodriguez, David M Asmuth, Roy M Matining, et al.
Frontiers in Immunology|June 22, 2026
Type-1 inflammatory imprinting and programmed responsiveness to CD40L enhance Siglec-1-dependent HIV-1 trans-infection by dendritic cellsE Grace Bothwell, Allison E DePuyt, Colleen R Zaccard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 2, 2000
Association of race and gender with HIV-1 RNA levels and immunologic progressionK Anastos, S J Gange, B Lau, et al.
Pageof 33

Showing results (291-300 of 324) with videos related to

Sort By:
Pageof 33
Journal of Virology|July 17, 2015
Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal TissuesTianyu He, Egidio Brocca-Cofano, Delbert G Gillespie, et al.
Advances in Virology|January 28, 2012
Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 InfectionJ Spindler, J Hackett, X Qiu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2008
Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopesCurtis P McMurtrey, Alina Lelic, Paolo Piazza, et al.
Influenza and Other Respiratory Viruses|April 17, 2020
Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016Goundappa K Balasubramani, Mary Patricia Nowalk, Theresa M Sax, et al.
Journal of Virology|July 20, 2012
Early HLA-B*57-restricted CD8+ T lymphocyte responses predict HIV-1 disease progressionCatherine A Brennan, F Javier Ibarrondo, Catherine A Sugar, et al.
Plos Pathogens|April 21, 2017
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activationRajesh T Gandhi, Deborah K McMahon, Ronald J Bosch, et al.
Plos One|February 8, 2011
The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairmentTammy M Rickabaugh, Ryan D Kilpatrick, Lance E Hultin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 31, 2013
Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trialBenigno Rodriguez, David M Asmuth, Roy M Matining, et al.
Frontiers in Immunology|June 22, 2026
Type-1 inflammatory imprinting and programmed responsiveness to CD40L enhance Siglec-1-dependent HIV-1 trans-infection by dendritic cellsE Grace Bothwell, Allison E DePuyt, Colleen R Zaccard, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 2, 2000
Association of race and gender with HIV-1 RNA levels and immunologic progressionK Anastos, S J Gange, B Lau, et al.
Pageof 33